Literature DB >> 319822

Immunological measurements of conformational motility in regions of the myoglobin molecule.

J G Hurrell, J A Smith, S J Leach.   

Abstract

The conformational motilities of three regions of the sperm whale myoglobin molecule and of an isolated peptide of myoglobin have been examined by measuring the equilibrium constant for the native equilibrium nonnative transition. The immunological approach of Furie et al. (Furie, B., Schechter, A.N., Sachs D., and Anfinsen, C.B. (1975), J. Mol. Biol.92, 497-506) was used with convenient modifications. Antibodies specific to the nonnative conformations were used in assaying for competition between the radioactively labeled peptide and native myoglobin. Labeling was by 125I iodination of the peptide or its 3-(4-hydroxyphenyl)propionyl derivative, and separation of the immune complex from the free peptide was either by ammonium sulfate precipitation or by centrifugation of the antibodies immobilized on Agarose beads. For the antigenic regions of the sequence (1-55), the measured conformational equilibrium constant was 840 +/- 200 at 22 degrees C; the value for the C-terminal region (132-153) was 280 +/- 120 at 25 degrees C, while that for the region (66-76) adjacent to the heme group was greater than 2.5 x 10(6). Measurements on the isolated peptide (132-153) indicated that 1% of the molecules adopt native-type folding in aqueous solution at 36 degrees C.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 319822     DOI: 10.1021/bi00621a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Antibody-detected folding: kinetics of surface epitope formation are distinct from other folding phases.

Authors:  C S Raman; R Jemmerson; B T Nall
Journal:  Protein Sci       Date:  2000-01       Impact factor: 6.725

2.  Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides.

Authors:  E Vives; P Charneau; J van Rietschoten; H Rochat; E Bahraoui
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

3.  Site-specific antibodies to human erythropoietin directed toward the NH2-terminal region.

Authors:  J M Sue; A J Sytkowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

4.  Monoclonal antibodies assisting refolding of firefly luciferase.

Authors:  Qin Xu; Zhiqun Xie; Jianfang Ding; Sheng-Xiang Lin; Genjun Xu
Journal:  Protein Sci       Date:  2004-07       Impact factor: 6.725

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.